|
|
|||
|
||||
OverviewThis book presents original research results on the leading edge of cancer. Topics discussed include the role of dendritic cells in the priming of cytotoxic T lymphocyte responses; current anti-cancer agents targeting apoptosis and authophagy and clues for future cancer drug discovery; the efficacy of bufadienolides and TCM preparations on in vivo and in vivo cancer models in clinical trials; the role of tetracyclic triterpenes and their glycosides in cancer prevention; adoptive cell therapy at the forefront of cancer immunotherapy; the challenges and promises of targeted chemoprevention; the physical, emotional and social challenges associated with cancer survivorship; bioinformatics tools and resources for cancer diagnosis and drug development; and the history of radical surgery for the treatment of prostate cancer. Full Product DetailsAuthor: Hiroto S WatanabePublisher: Nova Science Publishers Inc Imprint: Nova Science Publishers Inc Weight: 0.602kg ISBN: 9781624173288ISBN 10: 1624173284 Pages: 200 Publication Date: 10 May 2013 Audience: College/higher education , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsPriming of Cytotoxic T Lymphocyte Responses by Dendritic Cells: Induction of Potent Anti-Tumor Immune Responses; Programmed Cell Death in Cancer: Targeting Apoptosis & Autophagy Pathways as Therapeutic Strategies; A Critical Assessment of Anti-Cancer Activities of Bufadienolides; Cancer Chemopreventive Agents: Tetracyclic Triterpenoids; Adoptive Cell Therapy: At the Forefront of Cancer Immunotherapy; Targeted Chemoprevention: Challenges & Promises; After the Treatment Phase of Cancer Care: Physical Effects, Emotional Issues & Social Challenges Associated with Cancer Survivorship; Bioinformatics Tools & Resources for Cancer Diagnosis & Drug Development; The History of Radical Surgery for the Treatment of Prostate Cancer.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||